336 related articles for article (PubMed ID: 38680092)
21. Tissue distribution profiles of the human TRPM cation channel family.
Fonfria E; Murdock PR; Cusdin FS; Benham CD; Kelsell RE; McNulty S
J Recept Signal Transduct Res; 2006; 26(3):159-78. PubMed ID: 16777713
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta and its implication in the malignancy of gliomas.
Roy LO; Poirier MB; Fortin D
Target Oncol; 2015 Mar; 10(1):1-14. PubMed ID: 24590691
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
24. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
Shi Z; Chen Q; Li C; Wang L; Qian X; Jiang C; Liu X; Wang X; Li H; Kang C; Jiang T; Liu LZ; You Y; Liu N; Jiang BH
Neuro Oncol; 2014 Oct; 16(10):1341-53. PubMed ID: 24861879
[TBL] [Abstract][Full Text] [Related]
25. Targeting different domains of gap junction protein to control malignant glioma.
Wang J; Yang ZY; Guo YF; Kuang JY; Bian XW; Yu SC
Neuro Oncol; 2018 Jun; 20(7):885-896. PubMed ID: 29106645
[TBL] [Abstract][Full Text] [Related]
26. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma.
Di K; Lomeli N; Wood SD; Vanderwal CD; Bota DA
Oncotarget; 2016 Nov; 7(47):77457-77467. PubMed ID: 27764809
[TBL] [Abstract][Full Text] [Related]
28. Contribution and underlying mechanisms of lncRNA TRPM2-AS in the development and progression of human cancers.
Li F; Chen X
Pathol Res Pract; 2023 Nov; 251():154887. PubMed ID: 37871443
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
Liu M; Lin Y; Zhang XC; Tan YH; Yao YL; Tan J; Zhang X; Cui YH; Liu X; Wang Y; Bian XW
Lab Invest; 2017 Nov; 97(11):1354-1363. PubMed ID: 28759011
[TBL] [Abstract][Full Text] [Related]
30. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
31. TRPM Channels in Human Diseases.
Jimenez I; Prado Y; Marchant F; Otero C; Eltit F; Cabello-Verrugio C; Cerda O; Simon F
Cells; 2020 Dec; 9(12):. PubMed ID: 33291725
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.
Yang TQ; Lu XJ; Wu TF; Ding DD; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Guo LC; Zhang Y; Huang YL; Zhou YX; Du ZW
Cancer Sci; 2014 Mar; 105(3):265-71. PubMed ID: 24418124
[TBL] [Abstract][Full Text] [Related]
33. The role of TRPM channels in cell death.
McNulty S; Fonfria E
Pflugers Arch; 2005 Oct; 451(1):235-42. PubMed ID: 16025303
[TBL] [Abstract][Full Text] [Related]
34. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
[TBL] [Abstract][Full Text] [Related]
35. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
36. Mutations in chromatin machinery and pediatric high-grade glioma.
Lulla RR; Saratsis AM; Hashizume R
Sci Adv; 2016 Mar; 2(3):e1501354. PubMed ID: 27034984
[TBL] [Abstract][Full Text] [Related]
37. Gab2 expression in glioma and its implications for tumor invasion.
Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
[TBL] [Abstract][Full Text] [Related]
38. Elevated GIGYF2 expression suppresses tumor migration and enhances sensitivity to temozolomide in malignant glioma.
Yang W; Yuan Q; Zhang S; Zuo M; Li T; Li J; Zhou X; Li M; Feng W; Xia X; Chen M; Liu Y
Cancer Gene Ther; 2022 Jun; 29(6):750-757. PubMed ID: 34059782
[TBL] [Abstract][Full Text] [Related]
39. Pathological Mechanisms Induced by TRPM2 Ion Channels Activation in Renal Ischemia-Reperfusion Injury.
Khanahmad H; Mirbod SM; Karimi F; Kharazinejad E; Owjfard M; Najaflu M; Tavangar M
Mol Biol Rep; 2022 Nov; 49(11):11071-11079. PubMed ID: 36104583
[TBL] [Abstract][Full Text] [Related]
40. Ion Channels in Gliomas-From Molecular Basis to Treatment.
Elias AF; Lin BC; Piggott BJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
